SOLENO THERAPEUTICS INC 3 SEC Filings

Filed On	Filing
04 Mar 2026	Form 3: Fulk Jennifer, CHIEF FINANCIAL OFFICER No securities owned
19 Nov 2025	Form 3: Norrett Kevin, Chief Business Officer No securities owned
12 Nov 2025	Form 3: Joshi Manher, Chief Development Officer No securities owned
14 Oct 2025	Form 3: Hahn Mark W, Director No securities owned
23 Aug 2024	Form 3: Urbanski Raymond W., CHIEF DEVELOPMENT OFFICER No securities owned
16 Aug 2024	Form 3: Bir Dawn Carter, Director No securities owned
30 Apr 2024	Form 3: Manning Meredith, Chief Commercial Officer
30 Apr 2024	Form 3: Huang Michael F., Sr. VP of Clinical Development
16 Aug 2023	Form 3: Pauls Matthew, Director No securities owned
18 May 2023	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 1,864,455 shares of Common Stock
15 May 2023	Form 3: Vivo Opportunity, Llc, 10% owner and 1 other
11 Aug 2022	Form 3: Carlyle Group Inc., 10% owner and 7 others Holds 18,022,602 shares of Common Stock
20 Nov 2019	Form 3: Mackaness James H, Chief Financial Officer No securities owned
12 Jun 2019	Form 3: Volck Birgitte, Director No securities owned
29 Apr 2019	Form 3: Melincoff Gwen A, Director No securities owned
28 Jan 2019	Form 3: Hirano Patricia C, See Remarks No securities owned
27 Dec 2018	Form 3: Abingworth Llp, 10% owner Holds 4,669,272 shares of Common Stock
27 Dec 2018	Form 3: Sinclair Andrew, Director No securities owned
26 Dec 2018	Form 3: Schuler Jack W, 10% owner Holds 1,519,676 shares of Common Stock
20 Jun 2018	Form 3: Wolter Jonathan, Chief Financial Officer No securities owned

Comments